Business Description
LifeTech Scientific Corp
ISIN : KYG548721177
Total Employee Number:
1,240Compare
Compare
Traded in other countries / regions
01302.Hong Kong81X.GermanyLFTSF.USA IPO Date
2020-08-19Description
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 143.1 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 836.62 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.31 | |||||
Beneish M-Score | -0.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.3 | |||||
3-Year EBITDA Growth Rate | -13.2 | |||||
3-Year EPS without NRI Growth Rate | -24.8 | |||||
3-Year FCF Growth Rate | 97.4 | |||||
3-Year Book Growth Rate | 8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 31.88 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 15.34 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.78 | |||||
Days Inventory | 505.05 | |||||
Days Sales Outstanding | 44.37 | |||||
Days Payable | 339.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.7 | |||||
Shareholder Yield % | 7.94 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.4 | |||||
Operating Margin % | 12.89 | |||||
Net Margin % | 10.81 | |||||
EBITDA Margin % | 14.88 | |||||
FCF Margin % | 28.94 | |||||
OCF Margin % | 39.93 | |||||
ROE % | 4.16 | |||||
ROA % | 2.94 | |||||
ROIC % | 3.2 | |||||
3-Year ROIIC % | -20.08 | |||||
ROC (Joel Greenblatt) % | 16.91 | |||||
ROCE % | 4.88 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.3 | |||||
Forward PE Ratio | 25.94 | |||||
PE Ratio without NRI | 35.38 | |||||
Shiller PE Ratio | 25.23 | |||||
Price-to-Owner-Earnings | 27.06 | |||||
PS Ratio | 4.05 | |||||
PB Ratio | 1.56 | |||||
Price-to-Tangible-Book | 1.95 | |||||
Price-to-Free-Cash-Flow | 13.8 | |||||
Price-to-Operating-Cash-Flow | 10.07 | |||||
EV-to-EBIT | 23.12 | |||||
EV-to-EBITDA | 21.83 | |||||
EV-to-Revenue | 3.25 | |||||
EV-to-FCF | 11.19 | |||||
Price-to-GF-Value | 0.65 | |||||
Price-to-Projected-FCF | 1.23 | |||||
Price-to-Median-PS-Value | 0.36 | |||||
Price-to-Graham-Number | 1.8 | |||||
| Price-to-Net-Current-Asset-Value | 5.84 | |||||
Earnings Yield (Greenblatt) % | 4.33 | |||||
FCF Yield % | 7.19 | |||||
Forward Rate of Return (Yacktman) % | -4.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LFTSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LifeTech Scientific Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 192.647 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | 0.1669 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.44 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.2335 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.2335 - 0.2335 | ||
| Shares Outstanding (Mil) | 4,400.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LifeTech Scientific Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LifeTech Scientific Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
LifeTech Scientific Corp Frequently Asked Questions
What is LifeTech Scientific Corp(LFTSF)'s stock price today?
The current price of LFTSF is $0.23. The 52 week high of LFTSF is $0.23 and 52 week low is $0.23.
When is next earnings date of LifeTech Scientific Corp(LFTSF)?
The next earnings date of LifeTech Scientific Corp(LFTSF) is .
Does LifeTech Scientific Corp(LFTSF) pay dividends? If so, how much?
LifeTech Scientific Corp(LFTSF) does not pay dividend.
Guru Commentaries on OTCPK:LFTSF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on LifeTech Scientific Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers